Search

Disco and Beyond Disco with a Pharmacists’ Twist

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE This course will discuss the findings from Disco and a current study, Beyond Disco. This session will cover how to implement the findings from Disco in the clinic. The pharmacy session will discuss how to counsel patients on how to taper or reduce …

John Whitaker Lecture-The Illusion of Equivalence? Generic and Biosimilar Disease-Modifying Therapies in Multiple Sclerosis

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Multiple sclerosis (MS) represents a spectrum of demyelinating presentations with varying degrees of inflammatory activity and symptom expression, affecting nearly one million individuals in the U.S. The use of Food and Drug Administration (FDA)-approved disease-modifying therapies (DMTs) aim to reduce risk for clinical …

Current Topics and Trends in Rehabilitation Part 2: Part A: Neuromodulation for Functional Recovery in MS: The Role of Spinal Cord Stimulation Part B: Fatigue and Fatigability in MS: Mechanisms, Measurement and Management

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, IPCE Part A: Neuromodulation for Functional Recovery in MS: The Role of Spinal Cord Stimulation Spinal cord stimulation is a neuromodulation technique used to amplify sensorimotor recovery after neurologic injury. Historically, the need for implantable epidural stimulators has limited their use. …

Managing Non-Multiple Sclerosis Patients in a Multiple Sclerosis Practice: Rare Neuroimmunological Disorders – Everything You Need to Know Part 2

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE This session will introduce participants to the biologic and clinical basics of rare neuroimmune conditions such as neuromyelitis optic, anti-MOG associated disorder, autoimmune encephalitis, myelitis, neurosarcoidosis and stiff person syndrome. Participants will be educated about diagnostic criteria and appropriate …

Beyond the Label: Navigating Biomarkers, Supplements, and High-Risk Patients

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE This course will provide practical insights into clinical management strategies of multiple sclerosis. The presentations will focus on clinical implementation of biomarkers, management of high-risk patients and provide perspectives on supplements and MS care. Multiple sclerosis (MS) remains a clinically heterogeneous disease with …

Bugs and Drugs: Practical Management Considerations Around Infections and MS Disease Modifying Therapies

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Infections are associated with most MS disease modifying therapies, but the risks and related management strategies vary considerably. Our faculty of MS neurologists and advanced practice providers will review 1) what therapies have what infection risks, including rare infection risks; 2) risk factors …

Making the Invisible Visible

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Invisible symptoms of multiple sclerosis (MS), including fatigue, cognitive/mood impairment, and sensory disturbances, are major contributors to functional decline and diminished quality of life (QoL), yet remain understudied, underrecognized, and undertreated in people with MS. In this session, we …

Treating MS in 2025: Practical Issues and Special Considerations Organized by the VA MSCoE

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, IPCE This session will address common challenges in the pharmacological management of neuroimmunological conditions. The discussion will begin with special populations, including pregnant and lactating women and older adults. These life stages are characterized by the potential for spontaneous remission of …